NDC 49702-231

Triumeq

Abacavir Sulfate, Dolutegravir Sodium, Lamivudine

Triumeq is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Abacavir Sulfate; Dolutegravir Sodium; Lamivudine.

Product ID49702-231_166cd280-b103-449c-8b8b-8210b994cc52
NDC49702-231
Product TypeHuman Prescription Drug
Proprietary NameTriumeq
Generic NameAbacavir Sulfate, Dolutegravir Sodium, Lamivudine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2014-08-22
Marketing CategoryNDA / NDA
Application NumberNDA205551
Labeler NameViiV Healthcare Company
Substance NameABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
Active Ingredient Strength600 mg/1; mg/1; mg/1
Pharm ClassesHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 49702-231-13

30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13)
Marketing Start Date2014-08-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49702-231-13 [49702023113]

Triumeq TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA205551
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-08-22

Drug Details

Active Ingredients

IngredientStrength
ABACAVIR SULFATE600 mg/1

OpenFDA Data

SPL SET ID:2997739a-aa91-42aa-a206-a70e2db7b84f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1546888
  • 1546894
  • Pharmacological Class

    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • HIV Integrase Inhibitors [MoA]
    • Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
    • Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]
    • Organic Cation Transporter 2 Inhibitors [MoA]
    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]

    Medicade Reported Pricing

    49702023113 TRIUMEQ 600-50-300 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Triumeq" or generic name "Abacavir Sulfate, Dolutegravir Sodium, Lamivudine"

    NDCBrand NameGeneric Name
    49702-231Triumeqabacavir sulfate, dolutegravir sodium, lamivudine
    50090-1606Triumeqabacavir sulfate, dolutegravir sodium, lamivudine
    49702-258Triumeq PDabacavir sulfate, dolutegravir sodium, lamivudine

    Trademark Results [Triumeq]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TRIUMEQ
    TRIUMEQ
    77650550 4000175 Live/Registered
    VIIV HEALTHCARE COMPANY
    2009-01-15

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.